18F-F-AraG PET Imaging to Evaluate Immunological Response to CAR T Cell Therapy in Lymphoma
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
This is a pilot study in adult subjects with aggressive B-cell lymphoma who will receive
commercial or research CAR T cell therapy as anticancer treatment.